Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients

Due to the severe side effects of long-term treatment using hormone replacement therapy, Raloxifene (RLX) is introduced with beneficial effects on rheumatoid arthritis (RA) for postmenopausal women. This review was conducted to collect data from the available literature on RLX for the management of...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:European Pharmaceutical Journal
المؤلفون الرئيسيون: Salari M., Sahebary M., Sarafraz M., Asadi Sakhmarresi T.
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Sciendo 2023-09-01
الموضوعات:
autoimmunity
raloxifene
rheumatoid arthritis
osteoporosis
postmenopausal
الوصول للمادة أونلاين:https://doi.org/10.2478/afpuc-2023-0003
الوصف
الملخص:Due to the severe side effects of long-term treatment using hormone replacement therapy, Raloxifene (RLX) is introduced with beneficial effects on rheumatoid arthritis (RA) for postmenopausal women. This review was conducted to collect data from the available literature on RLX for the management of postmenopausal women suffering from RA.
تدمد:2453-6725

مواد مشابهة